Stereotactic body radiation therapy: A promising chance for oligometastatic breast cancer

Breast

Volumn 26, Issue , 2016, Pages 11-17

  Scorsetti, Marta ^a   Franceschini, Davide ^a   De Rose, Fiorenza ^a   Comito, Tiziana ^a   Villa, Elisa ^a   Iftode, Cristina ^a   Navarria, Pierina ^a   D'Agostino, Giuseppe Roberto ^a   Masci, Giovanna ^a   Torrisi, Rosalba ^a   Testori, Alberto ^a   Tinterri, Corrado ^a   Santoro, Armando ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

Breast cancer; Liver; Lung; RapidArc; Stereotactic body radiation therapy

Indexed keywords

HORMONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST METASTASIS; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; FOLLOW UP; HUMAN; INFORMED CONSENT; LIVER METASTASIS; LUNG METASTASIS; MIDDLE AGED; OBSERVATIONAL STUDY; OLIGOMETASTATIC BREAST CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; SAFETY; STEREOTACTIC BODY RADIATION THERAPY; VERY ELDERLY; BREAST TUMOR; DISEASE FREE SURVIVAL; FEMALE; LIVER TUMOR; LUNG TUMOR; MORTALITY; PATHOLOGY; PROCEDURES; RADIOSURGERY; SECONDARY; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MIDDLE AGED; RADIOSURGERY; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84961841977     PISSN: 09609776     EISSN: 15323080     Source Type: Journal    
DOI: 10.1016/j.breast.2015.12.002     Document Type: Article

References (29)

1. O'Shaughnessy J., Miles D., Vukelja S., Moiseyenko V., Ayoub J.P., Cervantes G., et al. Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial results. J Clin Oncol 2002, 20:2812-2823.
2. Tan S.-H., Wolff A.C. Treatment of metastatic breast cancer. Diseases of the breast 2010, 877-919. Wolters Kluwer/Lippincott Williams & Wilkins, Philadelphia, chemotherapy. 4th ed. J.R. Harris, M.E. Lippman, M. Morrow, C.K. Osborne (Eds.).
3. Pagani O., Senkus E., Wood W., Colleoni M., Cufer T., Kyriakides S., et al. International guidelines for management of metastatic breast cancer: can metastatic breast cancer be cured?. J Natl Cancer Inst 2010, 102:456-463.
4. Hortobagyi G.N. Can we cure limited metastatic breast cancer?. J Clin Oncol 2002, 20:620-623. 5.
5. Greenberg P.A., Hortobagyi G.N., Smith T.L., Ziegler L.D., Frye D.K., Buzdar A.U. Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer. J Clin Oncol 1996, 14:2197-2205.
6. Yamamoto N., Katsumata N., Watanabe T., Omuro Y., Ando M., Narabayashi M., et al. Clinical characteristics of patients with metastatic breast cancer with complete remission following systemic treatment. Jpn J Clin Oncol 1998, 28:368-373.
7. Tomiak E., Piccart M., Mignolet F., Sahmoud T., Paridaens R., Nooy M., et al. Characterisation of complete responders to combination chemotherapy for advanced breast cancer: a retrospective EORTC Breast Group study. Eur J Cancer 1996, 32A:1876-1887.
8. Hellman S. Karnofsky memorial lecture: natural history of small breast cancers. J Clin Oncol 1994, 12:2229-2234.
9. Dellas K. Does radiotherapy have curative potential in metastatic patients? the concept of local therapy in oligometastatic breast cancer. Breast Care 2011, 6:363-368.
10. Milano M.T., Katz A.W., Zhang H., Okunieff P. Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study. Int J Radiat Oncol Biol Phys 2012, 83:878-886.
11. Tree A.C., Khoo V.S., Eeles R.A., Ahmed M., Dearnaley D.P., Hawkins M.A., et al. Stereotactic body radiotherapy for oligometastases. Lancet Oncol 2013, 14:e28-37.
12. van Dongen J.A., van Slooten E.A. The surgical treatment of pulmonary metastases. Cancer Treat Rev 1978, 5:29-48.
13. Navarria P., Ascolese A.M., Cozzi L., Tomatis S., D'Agostino G.R., De Rose F., et al. Stereotactic body radiation therapy for lung metastases from soft tissue sarcoma. Eur J Cancer 2015 Mar, 51(5):668-674.
14. Scorsetti M., Comito T., Tozzi A., Navarria P., Fogliata A., Clerici E., et al. Final results of a phase II trial for stereotactic body radiation therapy for patients with inoperable liver metastases from colorectal cancer. J Cancer Res Clin Oncol 2015 Mar, 141(3):543-553.
15. Kavanagh B.D., McGarry R.C., Timmerman R.D. Extracranial radiosurgery (stereotactic body radiation therapy) for oligometastases. Semin Radiat 2006, 16:77-84.
16. Timmerman R.D., Kavanagh B.D., Cho L.C., Papiez L., Xing L. Stereotactic body radiation therapy in multiple organ sites. J Clin Oncol 2007, 25:947-952.
17. Salama J.K., Hasselle M.D., Chmura S.J., Malik R., Mehta N., Yenice K.M., et al. Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease. Cancer 2012, 118:2962-2970.
18. Milano M.T., Zhang H., Metcalfe S.K., Muhs A.G., Okunieff P. Oligometastatic breast cancer treated with curative-intent stereotactic body radiation therapy. Breast Cancer Res Treat 2009, 115:601-608.
19. Mehta N., Mauer A.M., Hellman S., Haraf D.J., Cohen E.E., Vokes E.E., et al. Analysis of further disease progression in metastatic non-small cell lung cancer: implications for locoregional treatment. Int J Oncol 2004, 25:1677-1683.
20. Salama J.K., Chmura S.J. Surgery or ablative radiotherapy for breast cancer oligometastases. Am Soc Clin Oncol Educ Book 2015, 35:e8-e15.
21. Abbott D.E., Brouquet A., Mittendorf E.A., Andreou A., Meric-Bernstam F., Valero V. Resection of liver metastases from breast cancer: estrogen receptor status and response to chemotherapy before metastasectomy define outcome. Surgery 2012, 151:710-716.
22. Pockaj B.A., Wasif N., Dueck A.C., Wigle D.A., Boughey J.C., Degnim A.C. Metastasectomy and surgical resection of the primary tumor in patients with stage IV breast cancer: time for a second look?. Ann Surg Oncol 2010, 17:2419-2426.
23. de Vin T., Engels B., Gevaert T., Storme G., De Ridder M. Stereotactic radiotherapy for oligometastatic cancer: a prognostic model for survival. Ann Oncol 2014, 25:467-471.
24. Kobayashi T., Ichiba T., Sakuyama T. Possible clinical cure of metastatic breast cancer: lessons from our 30-year experience with oligometastatic breast cancer patients and literature review. Breast Cancer 2012, 19:218-237.
25. Fode M.M., Hoyer M. Survival and prognostic factors in 321 patients treated with stereotactic body radiotherapy for oligo-metastases. Radiother Oncol 2015 Feb, 114(2):155-160.
26. Mack M.G., Straub R., Ecihler K., Sollner O., Lehnert T., Vogl T.J. Breast cancer metastases in liver: laser-induced interstitial thermotherapy-local tumor control rate and survival data. Radiology 2004 Nov, 233(2):400-409.
27. Vogl T.J., Farshid P., Naguib N.N., Zangos S. Thermal ablation therapies in patients with breast cancer liver metastases: a review. Eur Radiol 2013 Mar, 23(3):797-804.
28. Treasure T. Oligometastatic cancer: an entity, a useful concept, or a therapeutic opportunity?. J R Soc Med 2012, 105:242-246.
29. Blackwell K.L., Burstein H.J., Storniolo A.M., Rugo H.S., Sledge G., Aktan G., et al. Overall survival benefit with lapatinib in combination with trastuzumab for patients with human epidermal growth factor receptor 2-positive metastatic breast cancer: final results from the EGF104900 Study. J Clin Oncol 2012, 30:2585-2592.